Lotte Chemical Titan Holding Berhad

KLSE:LCTITAN Stock Report

Market Cap: RM 1.8b

Lotte Chemical Titan Holding Berhad Valuation

Is LCTITAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LCTITAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LCTITAN (MYR0.78) is trading above our estimate of fair value (MYR0.02)

Significantly Below Fair Value: LCTITAN is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LCTITAN?

Key metric: As LCTITAN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LCTITAN. This is calculated by dividing LCTITAN's market cap by their current revenue.
What is LCTITAN's PS Ratio?
PS Ratio0.2x
SalesRM 7.50b
Market CapRM 1.81b

Price to Sales Ratio vs Peers

How does LCTITAN's PS Ratio compare to its peers?

The above table shows the PS ratio for LCTITAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.8x
SENFONG Seng Fong Holdings Berhad
0.7x8.4%RM 772.2m
SCIENTX Scientex Berhad
1.6x7.1%RM 7.0b
BKAWAN Batu Kawan Berhad
0.3xn/aRM 7.9b
SAB Southern Acids (M) Berhad
0.5xn/aRM 438.2m
LCTITAN Lotte Chemical Titan Holding Berhad
0.2x9.6%RM 1.8b

Price-To-Sales vs Peers: LCTITAN is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.8x).


Price to Sales Ratio vs Industry

How does LCTITAN's PS Ratio compare vs other companies in the MY Chemicals Industry?

0 CompaniesPrice / SalesEstimated GrowthMarket Cap
No more companies available in this PS range
LCTITAN 0.2xIndustry Avg. 1.2xNo. of Companies5PS00.81.62.43.24+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: LCTITAN is good value based on its Price-To-Sales Ratio (0.2x) compared to the MY Chemicals industry average (1.2x).


Price to Sales Ratio vs Fair Ratio

What is LCTITAN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LCTITAN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: LCTITAN is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LCTITAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 0.78
RM 1.05
+34.8%
19.8%RM 1.39RM 0.86n/a4
Nov ’25RM 0.97
RM 1.08
+10.8%
17.2%RM 1.39RM 0.93n/a4
Oct ’25RM 1.02
RM 1.08
+5.9%
17.2%RM 1.39RM 0.93n/a4
Sep ’25RM 1.02
RM 1.08
+5.9%
17.2%RM 1.39RM 0.93n/a4
Aug ’25RM 1.06
RM 1.08
+1.9%
17.2%RM 1.39RM 0.93n/a4
Jul ’25RM 1.28
RM 1.07
-16.2%
17.5%RM 1.39RM 0.93n/a4
Jun ’25RM 1.09
RM 1.07
-1.6%
17.5%RM 1.39RM 0.93n/a4
May ’25RM 1.10
RM 1.08
-1.8%
17.1%RM 1.39RM 0.93n/a4
Apr ’25RM 1.13
RM 1.08
-4.4%
17.1%RM 1.39RM 0.93n/a4
Mar ’25RM 1.15
RM 1.08
-6.1%
17.1%RM 1.39RM 0.93n/a4
Feb ’25RM 1.20
RM 1.08
-10.0%
17.1%RM 1.39RM 0.93n/a4
Jan ’25RM 1.35
RM 1.04
-23.3%
17.6%RM 1.32RM 0.83n/a4
Dec ’24RM 1.16
RM 1.04
-10.8%
17.6%RM 1.32RM 0.83n/a4
Nov ’24RM 1.11
RM 1.04
-6.8%
17.6%RM 1.32RM 0.83RM 0.974
Oct ’24RM 1.16
RM 1.11
-4.5%
24.2%RM 1.56RM 0.86RM 1.024
Sep ’24RM 1.23
RM 1.11
-10.0%
24.2%RM 1.56RM 0.86RM 1.024
Aug ’24RM 1.15
RM 1.11
-3.7%
24.2%RM 1.56RM 0.86RM 1.064
Jul ’24RM 1.17
RM 1.17
-0.2%
21.1%RM 1.56RM 0.93RM 1.284
Jun ’24RM 1.23
RM 1.25
+2.0%
22.3%RM 1.60RM 0.93RM 1.095
May ’24RM 1.25
RM 1.31
+4.9%
21.8%RM 1.60RM 0.93RM 1.106
Apr ’24RM 1.35
RM 1.32
-2.2%
21.0%RM 1.60RM 0.93RM 1.136
Mar ’24RM 1.36
RM 1.32
-2.9%
21.0%RM 1.60RM 0.93RM 1.156
Feb ’24RM 1.57
RM 1.37
-13.1%
20.1%RM 1.60RM 0.93RM 1.206
Jan ’24RM 1.42
RM 1.44
+1.3%
16.3%RM 1.64RM 0.94RM 1.357
Dec ’23RM 1.61
RM 1.46
-9.2%
17.8%RM 1.80RM 0.94RM 1.167
Nov ’23RM 1.30
RM 1.46
+12.4%
17.8%RM 1.80RM 0.94RM 1.117

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies